Scleritis: Clinical Trials

3 trials for Scleritis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 23Completed 3

Follow Scleritis: new trials by email Literature Review of Scleritis trials Research Report on Scleritis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Gevokizumab for Active Scleritis
Gevokizumab - Scleritis
Phase 1 / Phase 2CompletedNational Eye Institute (NEI)82013-03-012018-07-06
Sirolimus Injections for Autoimmune Scleritis
Sirolimus - Scleritis
Phase 1 / Phase 2CompletedNational Eye Institute (NEI)52012-01-012020-06-19
Rituximab in the Treatment of Scleritis and Non-Infectious Orbital Inflammation
Rituximab - Scleritis, Orbital Disease
Phase 1 / Phase 2CompletedOregon Health and Science University202007-01-012013-08-16

Narrower conditions

Orbital Diseases (1)

Broader conditions

Eye Diseases (3)  ·  Scleral Diseases (3)

Interventions

Rituximab (1)  ·  Sirolimus (1)

Sponsors

National Eye Institute (NEI) (2)  ·  Oregon Health and Science University (1)

Countries

United States (3)

Top investigators

Hatice N Sen, M.D. (2)  ·  Eric B Suhler, MD (1)  ·  James T Rosenbaum, MD (1)

Results publications

PMID 24652467, PMID 25526946, PMID 27663070